BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 33402221)

  • 1. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
    Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
    J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.
    Neipp M; Zorina T; Domenick MA; Exner BG; Ildstad ST
    Blood; 1998 Nov; 92(9):3177-88. PubMed ID: 9787154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
    de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
    Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.
    Yan XQ; Hartley C; McElroy P; Chang A; McCrea C; McNiece I
    Blood; 1995 May; 85(9):2303-7. PubMed ID: 7537109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor.
    Wagers AJ; Allsopp RC; Weissman IL
    Exp Hematol; 2002 Feb; 30(2):176-85. PubMed ID: 11823053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.
    Wright DE; Cheshier SH; Wagers AJ; Randall TD; Christensen JL; Weissman IL
    Blood; 2001 Apr; 97(8):2278-85. PubMed ID: 11290588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
    Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
    Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
    Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
    Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effects of exercise training on hematopoietic stem cell quantity and function.
    De Lisio M; Parise G
    J Appl Physiol (1985); 2012 Nov; 113(10):1576-84. PubMed ID: 23019311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.
    Wang TF; Liou YS; Yang SH; Lin GL; Chiang YW; Lien TS; Li CC; Wang JH; Chang HH; Sun DS
    Stem Cell Res Ther; 2023 Oct; 14(1):300. PubMed ID: 37864264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.
    Winkler IG; Pettit AR; Raggatt LJ; Jacobsen RN; Forristal CE; Barbier V; Nowlan B; Cisterne A; Bendall LJ; Sims NA; Lévesque JP
    Leukemia; 2012 Jul; 26(7):1594-601. PubMed ID: 22266913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony stimulating factor expands hematopoietic stem cells within the central but not endosteal bone marrow region.
    Grassinger J; Williams B; Olsen GH; Haylock DN; Nilsson SK
    Cytokine; 2012 May; 58(2):218-25. PubMed ID: 22341722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
    Sudo Y; Shimazaki C; Ashihara E; Kikuta T; Hirai H; Sumikuma T; Yamagata N; Goto H; Inaba T; Fujita N; Nakagawa M
    Blood; 1997 May; 89(9):3186-91. PubMed ID: 9129021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
    Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
    Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
    Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
    Di Giacomo F; Lewandowski D; Cabannes E; Nancy-Portebois V; Petitou M; Fichelson S; Romeo PH
    Haematologica; 2012 Apr; 97(4):491-9. PubMed ID: 22180429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.
    Szumilas P; Barcew K; Baśkiewicz-Masiuk M; Wiszniewska B; Ratajczak MZ; Machaliński B
    Cell Prolif; 2005 Feb; 38(1):47-61. PubMed ID: 15679866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.